290 related articles for article (PubMed ID: 22967385)
21. The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
Jacquemin M; Vanlinthout I; Van Horenbeeck I; Debasse M; Toelen J; Schoeters J; Lavend'homme R; Freson K; Peerlinck K
Int J Lab Hematol; 2017 Jun; 39(3):301-307. PubMed ID: 28318107
[TBL] [Abstract][Full Text] [Related]
22. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
[TBL] [Abstract][Full Text] [Related]
23. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of molecular pathogenesis and clinical phenotypes in 10 probands with inherited fibrinogen deficiency].
Zhu L; Zhao M; Lin J; Wang Y; Xie H; Xie Y; Ding H; Wang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):793-6. PubMed ID: 26663050
[TBL] [Abstract][Full Text] [Related]
25. [Phenotype and genotype analyses of two pedigrees with inherited fibrinogen deficiency].
Jia KQ; Su ZX; Chen HL; Zheng XY; Zeng ML; Zhang K; Ye LY; Yang LL; Jin YH; Wang MS
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):930-935. PubMed ID: 38185523
[No Abstract] [Full Text] [Related]
26. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze).
Undas A; Pastuszczak M; Iwaniec T; Kapelak K; Neerman-Arbez M
Thromb Haemost; 2010 Aug; 104(2):415-7. PubMed ID: 20508898
[No Abstract] [Full Text] [Related]
27. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
Miesbach W; Galanakis D; Scharrer I
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
[TBL] [Abstract][Full Text] [Related]
28. A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution.
Zhou N; Xu P; Zhou M; Xu Y; Li P; Chen B; Ouyang J; Zhou R
J Thromb Thrombolysis; 2017 Jul; 44(1):139-144. PubMed ID: 28425010
[TBL] [Abstract][Full Text] [Related]
29. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
30. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
[TBL] [Abstract][Full Text] [Related]
31. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
32. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
Amri Y; Jouini H; Becheur M; Dabboubi R; Mahjoub B; Messaoud T; Sfar MT; Casini A; de Moerloose P; Toumi NEH
Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
[TBL] [Abstract][Full Text] [Related]
36. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of two pedigrees affected with inherited dysfibrinogenemia due to a novel c.1115 T>A variant of the FGB gene].
Wang X; Yao Y; Lin S; Wang J; Shu K; Ai X; Jiang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jun; 39(6):587-591. PubMed ID: 35773760
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
